Mardia Samyoun Capillary Tubes Allots 78,15,000 Equity Shares Through Warrant Conversion
Mardia Samyoun Capillary Tubes Company Limited successfully allotted 78,15,000 equity shares through warrant conversion on April 11, 2026, to two non-promoter investors. The warrants, originally issued at INR 13.50 each on February 06, 2026, were converted into equity shares with face value INR 10 each. This conversion increased the company's paid-up capital from INR 67,73,30,730 to INR 75,54,80,730, expanding the total share count from 6,77,33,073 to 7,55,48,073 shares.
*this image is generated using AI for illustrative purposes only.
Mardia Samyoun Capillary Tubes Company Limited has completed the allotment of 78,15,000 equity shares through the conversion of fully convertible equity warrants, marking a significant expansion in its equity base. The board of directors approved this conversion during their meeting held on April 11, 2026, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Warrant Conversion Details
The converted warrants were originally allotted on February 06, 2026, at an issue price of INR 13.50 per warrant on a preferential basis to non-promoter category investors. Each equity share carries a face value of INR 10.
| Parameter: | Details |
|---|---|
| Total Warrants Converted: | 78,15,000 |
| Face Value per Share: | INR 10 |
| Original Issue Price: | INR 13.50 per warrant |
| Allotment Date: | February 06, 2026 |
| Conversion Date: | April 11, 2026 |
Allottee Distribution
The equity shares have been distributed between two non-promoter investors as detailed in the preferential allotment structure.
| Allottee Name: | Category | Shares Allotted |
|---|---|---|
| Patel Biralkumar Rajeshbhai: | Non-Promoter | 39,50,000 |
| Shaikh Sajidbhai Rahimbhai: | Non-Promoter | 38,65,000 |
| Total: | 78,15,000 |
Impact on Share Capital
The warrant conversion has resulted in a substantial increase in the company's paid-up equity share capital. This expansion reflects the company's capital raising activities and provides additional financial resources for business operations.
| Capital Structure: | Before Conversion | After Conversion |
|---|---|---|
| Paid-up Capital: | INR 67,73,30,730 | INR 75,54,80,730 |
| Number of Shares: | 6,77,33,073 | 7,55,48,073 |
| Face Value: | INR 10 per share | INR 10 per share |
Board Meeting Proceedings
The board meeting that approved the warrant conversion was conducted on April 11, 2026, commencing at 04:30 PM and concluding at 05:00 PM. The decision was made in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring full regulatory compliance.
The conversion represents the completion of the warrant exercise process that began with the original preferential allotment in February 2026, demonstrating investor confidence in the company's prospects and providing additional equity capital for future growth initiatives.
How will the INR 105.5 crore capital infusion be deployed across Mardia Samyoun's capillary tube manufacturing operations and expansion plans?
What impact might the 15% dilution in existing shareholding have on the company's stock price and trading dynamics?
Will the significant stake acquired by the two non-promoter investors lead to changes in the company's board composition or strategic direction?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
